Le Lézard
Classified in: Health, Science and technology
Subjects: PARTNERSHIPS, HEALTH, MISCELLANEOUS

Philips employees and Philips Foundation join forces in the fight on childhood pneumonia


November 14, 2019

Focused program of partnerships, collaboration, funding and volunteering addresses the community-level prevention, diagnosis and treatment of a disease that takes the lives of around 800,000 under-five-year-olds each year, mostly in disadvantaged communities.

Amsterdam, the Netherlands ? Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the Philips Foundation, with its mission to reduce healthcare inequality by providing access to quality healthcare for disadvantaged communities, today announced the achievements of a year-long program of collaborations to reduce infant mortality rates for childhood pneumonia, a disease that currently claims the lives of around 800,000 under-five-year-olds a year [1] ? equivalent to one every 39 seconds.

Combining the volunteering activities of Philips' 80,000 employees, local stakeholder engagement, accessible and affordable technology, and the scale-up capabilities of international NGOs, this childhood pneumonia program exemplifies the Philips Foundation's commitment to drive and support initiatives that deliver long-term system change and achieve lasting impact. During the past 12 months, the program is estimated to have created access to better care for more than 700,000 people, in countries as widespread as Afghanistan, Ethiopia, Nicaragua, Malawi and India.

"The mission of the Philips Foundation is to reduce healthcare inequality by providing access to quality healthcare for disadvantaged communities," said Ronald de Jong, Chairman of the Philips Foundation Board. "Focusing our year-long volunteering efforts on a single global healthcare issue that disproportionately affects disadvantaged communities, created a multiplier effect, supporting ways to overcome the challenges, and ensuring long-term impact."

Childhood pneumonia
Pneumonia in children under five was chosen as the 2018-2019 topic for Philips' employee volunteering, due to its many casualties, and the fact that respiratory disease is one of the expert fields of Philips that the foundation can tap into. Caused by viral, bacterial, or fungal infection of the lungs, childhood pneumonia can be prevented by immunization, a healthier diet and improved environmental conditions [2] ? for example, better (indoor) air quality. Although bacterial pneumonia can be effectively treated with low-cost antibiotics, only a third of children receive them in time [2]. The accurate determination of rapid breathing, which is the principal early indicator of childhood pneumonia, can be achieved by leveraging the power of artificial intelligence (AI) in affordable diagnostic devices.

Examples of the supported and initiated activities of the Philips Foundation over the past 12 months, conducted through global partnerships, local projects and support of social entrepreneurs, are listed below:

[1] data.unicef.org/topic/child-health/pneumonia
[2] www.who.int/news-room/fact-sheets/detail/pneumonia

For further information, please contact:

Ben Zwirs
Philips Global Press Office
Tel.: +31 6 15213446
E-mail: [email protected]

Yannick Eshuijs
Philips Foundation
Tel. : +31 6 18526633
E-mail: [email protected]
Twitter: @PhilipsFDN

About the Philips Foundation
The Philips Foundation is a registered charity that was established in July 2014 as the central platform for Philips' CSR activities. Reflecting our commitment to United Nations Sustainable Development Goals 3 (Ensure healthy lives and promote well-being for all at all ages) and 17 (Revitalize the global partnership for sustainable development), the mission of the Foundation is to reduce healthcare inequality by providing access to quality healthcare for disadvantaged communities. We do this by deploying Philips' expertise, innovative products and solutions, by collaborating with key partners around the world and by providing financial support for collaborative activities. More information on the Philips Foundation can be found at www.philips-foundation.com.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2018 sales of EUR 18.1 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

 

Attachments


These press releases may also interest you

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

3 jui 2024
On July 02, 2024, the BC Government designated Psychotherapy as a Health Profession under the Health Professions Act. The proposal received cabinet approval and was subsequently signed by the Lieutenant Governor. The official order can be viewed...

3 jui 2024
Whitman-Walker Institute condemns the politically motivated ruling from a federal district court judge that blocks vital nondiscrimination protections for transgender people across the country. Today, a U.S. district court judge in Mississippi issued...



News published on and distributed by: